Z-VAD-FMK treatment inhibits caspase-3 cleavage and CA alone mediates caspase-3 cleavage in CA-induced GC cells; however, Z-VAD-FMK suppresses caspase-3 cleavage in CA-treated GC cells (Fig. 1h). This evidence concerns the gene CASP3 and gastric cancer.